Metraipolis › archive › dc_94fb8daa3d95

Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy — Europe PMC PMID:41010829

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41010829
DOI
10.3390/jcm14186610
License (as archived)
solo-consultazione
Archived
2026-11-09T20:34:43.175Z
SHA-256 of the archived text
118adebce0f33e393ea3908b708b969bcc4dcd45d93d5102f9ecbc5869c9635d
Stable URL of this page
https://metraipolis.com/documento/dc_94fb8daa3d95

How to cite

Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy — Europe PMC PMID:41010829 — Europe PMC (en), https://europepmc.org/article/MED/41010829 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_94fb8daa3d95 (Metraipolis archive dc_94fb8daa3d95, sha256 118adebce0f33e393ea3908b708b969bcc4dcd45d93d5102f9ecbc5869c9635d)
BibTeX
@misc{dc94fb8daa3d95,
  title = {Clinical Characteristics and Management of Statin-Associated Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy — Europe PMC PMID:41010829},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41010829},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_94fb8daa3d95; sha256 118adebce0f33e393ea3908b708b969bcc4dcd45d93d5102f9ecbc5869c9635d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41010829. Agents can read the archived copy with the MCP tool read_document.